Events

Meet Cogstate experts at these upcoming industry events around the globe.

Loading Events

Past Events

Find Events

Event Views Navigation

March 2019

AD/PD 2019, the 14th​ International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

March 26, 2019 - March 31, 2019

AD/PD 2019 is focused on unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and other related neurodegenerative diseases.​​ At this year’s 14th​ International Conference, Cogstate scientists will contribute to oral presentations and scientific posters on the following topics:

TitleREAL-WORLD OUTCOMES FOR ALZHEIMER’S DISEASE
Authors: C. Edgar
Session: Pre-conference Symposium: The Promise and Pitfalls of Real World Evidence in Alzheimer’s Disease
Date: March 26

TitleTHE COGSTATE COMPUTERIZED COGNITIVE TEST BATTERY AS A SINGLE PRIMARY ENDPOINT IN PRECLINICAL ALZHEIMER’S DISEASE
Authors: C. Edgar, A. Schembri, P. Maruff
Session: A4.J. Imaging, Biomarkers, Diagnostics: Cognitive, Psychometric & Behavioral Tests
Date: March 27

Title: CULTURAL ADAPTATION OF A VERBAL EPISODIC MEMORY TEST, THE INTERNATIONAL SHOPPING LIST TEST (ISLT)
Authors: C. Edgar, A. Schembri, E. Bove, P. Maruff
Session: A4.J. Imaging, Biomarkers, Diagnostics: Cognitive, Psychometric & Behavioral Tests
Date: March 27

Title: PERFORMANCE ON THE INTERNATIONAL SHOPPING LIST TEST AND SUBSEQUENT AMYLOID PET POSITIVITY RATES IN THE ELENBECESTAT MissionAD PHASE 3 PROGRAM
Authors: C M. Gee, M. Kanekiyo, P. Maruff, A. Schembri, B. Albala
Session: A4.J. Imaging, Biomarkers, Diagnostics: Cognitive, Psychometric & Behavioral Tests
Date: March 27

TitleA POLYGENIC RISK SCORE DERIVED FROM EPISODIC MEMORY WEIGHTED GENETIC VARIANTS IS ASSOCIATED WITH COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER’S DISEASE
Authors: T. Porter, S. Burnham C, G. Savage, Y. Lim, P. Maruff, L. Milicic, M. Peretti, D. Ames, C. Masters L, R. Martins N, S. Rainey-Smith, C. Rowe C, O. Salvado, K. Taddei, D. Groth, G. Verdile, V. Villemagne L, S. Laws M
Session: Symposium 50: Genetic Mechanisms
Date: March 29

Title: ACCUMULATION OF AMYLOID IN COGNITIVELY NORMAL APOE4 CARRIERS PRIOR TO CLASSIFICATION OF PRECLINICAL ALZHEIMER’S DISEASE
Authors: P. Maruff, C. Dang, Y. Lim, V. Villemagne, C. Rowe, C. Masters
Session: SYMPOSIUM 70: BIOMARKERS AND IMAGING IN AD 3
Date: March 31

Find out more »

July 2019

AAIC 2019

July 14, 2019 - July 18, 2019

The Alzheimer’s Association International Conference is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that’ll lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.

Find out more »

August 2019

The RARE Patient Advocacy Summit (Global Genes)

August 18, 2019 - August 20, 2019

As the largest gathering of rare disease patients, caregivers, thought leaders and other rare disease stakeholders in the world, the RARE Patient Advocacy Summit is an unparalleled opportunity to forge meaningful connections with other rare advocates and take home actionable strategies and tools to accelerate change.

Find out more »

September 2019

ISCTM 2019 Autumn Conference

September 5, 2019 - September 7, 2019
Find out more »

ECNP Congress (European College of Neuropsychopharmacology)

September 7, 2019 - September 10, 2019

he ECNP Congress that occurs annually is Europe’s largest meeting on applied and translational neuroscience.
Held in autumn every year, the Congress brings together a vibrant group of psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders. With around 6000 participants, the ECNP congress is Europe’s premier showcase for new research, treatments and technologies in applied brain science. Spanning the spectrum of human mood, behaviour, cognition and emotion, the congress covers most brain-related aspects from basic science to clinical care.

Find out more »

ADDF Conference on Alzheimer’s Drug Discovery

September 16, 2019 - September 17, 2019

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and leading scientists in the field present their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

Find out more »

October 2019

NORD Rare Summit

October 21, 2019 - October 22, 2019

As technology in rare disease accelerates, and with topics like drug pricing being a top priority in government, we must act now to drive innovation and collaboration to develop stronger resources, better outcomes and find cures for the community. In 2019, we believe The Time is Now to prioritize action in making positive changes for the millions of Americans living with rare diseases.

Find out more »

November 2019

ADDF Fall Symposium Luncheon

November 1, 2019

The Ninth Annual Fall Symposium & Luncheon “Hope on the Horizon” comprised a morning symposium with leading Alzheimer’s researchers and a luncheon to present the Charles Evans Award.

Find out more »

ISPOR Europe 2019

November 2, 2019 - November 6, 2019

ISPOR Europe 2019 convenes an international, interdisciplinary audience of 5000+ healthcare stakeholders that include policy makers, payers, thought leaders, researchers, decision makers, and patient representatives.

Find out more »

December 2019

12th Clinical Trials on Alzheimer’s Disease (CTAD)

December 4, 2019 - December 7, 2019

The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments.

Find out more »

February 2020

SCOPE Summit

February 18 - February 21

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and an all new track on Medical Device Clinical Trial Operations and Regulations.

Find out more »

March 2020

ASENT 2019 (American Society for Experimental Neurotherapeutics)

March 2 - March 5

The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems.

Find out more »

ASCPT Annual Meeting

March 17 - March 21
Find out more »

April 2020

AAT-AD/PD Meeting 2020

April 2 - April 5

The Meeting will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

Find out more »

Congress of the Schizophrenia International Research Society (SIRS)

April 4 - April 8
Find out more »
+ Export Events